Armin Rabsteyn

TL;DR: This work identifies and characterize multiple dominant and subdominant SARS-CoV-2 HLA class I and HLA-DR peptides as potential T cell epitopes in COVID-19 convalescent and unexposed individuals to enable identification of heterologous and post-infectious T cell immunity and facilitate development of diagnostic, preventive and therapeutic measures for CO VID-19.

TL;DR: This study represents the first community-based effort to develop a robust platform for the reproducible and quantitative measurement of the entire repertoire of peptides presented by HLA molecules, an essential step towards the design of efficient immunotherapies.

TL;DR: This study comprehensively analyzed the immunopeptidomic landscape of ovarian carcinoma and compared it to variety of benign sources to identify antigens exclusively presented on tumor cells and provided important insights into the relationship between gene transcript levels and HLA ligand presentation.

TL;DR: Neutrophils have the capability of producing IFNα on selective triggering, and a natural lupus stimulus involved is identified, unveiling a new mechanism involved in SLE.

TL;DR: Administration of CD34+ selected SCBs from alternative donors is safe and effective in paediatric patients with PGF and patients who responded to SCB displayed a trend toward better overall survival (OS) (P = 0·07).